<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">In 2003, the government of China launched the “Four Free and One Care” policy [
 <xref ref-type="bibr" rid="CR26">26</xref>]. Since then, HAART has been available. However, along with the extensive use of HAART, HIV-1 drug resistance has become an issue in some areas of China. In some individuals receiving therapy, the ratio of HIV drug-resistant mutations was higher than 20% in some areas [
 <xref ref-type="bibr" rid="CR27">27</xref>]. In this study, a low level of drug-resistant strains was found in Shenzhen City both in 2013 and 2015. However, more drug-resistant variants were identified in 2015 compared to 2013, suggesting that the transmission of drug resistance has increased. Therefore, surveillance of HIV drug resistance is necessary in the region.
</p>
